Showing results (11-20 of 155) with videos related to
Sort By:
Pageof 16
Journal of Cellular Biochemistry|September 24, 2002
Mechanisms of cytotoxicity induced by horseradish peroxidase/indole-3-acetic acid gene therapyOlga Greco, Gabi U Dachs, Gillian M Tozer, et al.Frontiers in Bioscience : a Journal and Virtual Library|June 5, 2002
Cancer gene therapy: 'delivery, delivery, delivery'Olga Greco, Simon D Scott, Brian Marples, et al.BMJ (Clinical Research Ed.)|April 6, 2002
Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trialsAndrew G Renehan, Matthias Egger, Mark P Saunders, et al.Journal of Medicinal Chemistry|September 5, 2023
Structural Mechanism and Inhibitors Targeting EGFR Exon 20 Insertion (Ex20ins) MutationsHao Chen, Shiliang Hu, Adam V Patterson, et al.Molecules (Basel, Switzerland)|November 20, 2009
Bystander or no bystander for gene directed enzyme prodrug therapyGabi U Dachs, Michelle A Hunt, Sophie Syddall, et al.Cells|April 30, 2021
Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer ImmunotherapyZhe Fu, Alexandra M Mowday, Jeff B Smaill, et al.European Journal of Cancer Care|March 27, 2013
Is a nurse-led telephone intervention a viable alternative to nurse-led home care and standard care for patients receiving oral capecitabine? Results from a large prospective audit in patients with colorectal cancerOlive Craven, Carol Anne Hughes, Amy Burton, et al.Journal of the American Chemical Society|September 24, 2009
Spin trapping of radicals other than the *OH radical upon reduction of the anticancer agent tirapazamine by cytochrome P450 reductaseSujata S Shinde, Michael P Hay, Adam V Patterson, et al.International Journal of Radiation Oncology, Biology, Physics|January 31, 2004
The bioreductive agent RH1 and gamma-irradiation both cause G2/M cell cycle phase arrest and polyploidy in a p53-mutated human breast cancer cell lineJoo-Young Kim, Chul-Hwan Kim, Ian J Stratford, et al.Chemmedchem|January 3, 2019
TAS-120 Cancer Target Binding: Defining Reactivity and Revealing the First Fibroblast Growth Factor Receptor 1 (FGFR1) Irreversible StructureMaria Kalyukina, Yuliana Yosaatmadja, Martin J Middleditch, et al.Pageof 16